Table 3.
Parameter | Description | Dimension |
---|---|---|
1 / a | Days to clear a sensitive infection after treatment | T |
c | Per capita rate of IPT treatment administration | |
1 / r | Time chemoprophylaxis lasts in IPT-treated humans | T |
Time chemoprophylaxis lasts in symptomatic treated humans | T | |
b | Fraction of asymptomatic infected treated juveniles who become temporarily immune protected | 1 |
Fraction of asymptomatic infected treated mature humans who become temporarily immune protected | 1 | |
p | Efficacy of drugs used to clear resistant infections | 1 |